News and Community

Alzheimer’s Disease, Clinical Development, Diagnostic Technology, Diagnostics, Healthcare Technology, Ivd, Lucent Ad Complete, Precision Biomarker Science, Precision Medicine, Quanterix

September 15, 2026

Quanterix Selects Dr. Yuri Fesko to Serve as Chief Medical Officer